Dianthus Therapeutics (DNTH) has released an update to notify the public and investors about a regulation fd disclosure.
On January 22, 2024, the Company announced a Private Placement through a press release. The press release, included in the Current Report on Form 8-K, provides information that, while not considered filed under Section 18 of the Securities Exchange Act of 1934, nor incorporated by reference into the Company’s Securities Act filings, is disclosed per the reporting requirements.
For further insights into DNTH stock, check out TipRanks’ Stock Analysis page.
